These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 22670865)
1. Harm reduction and the medicalisation of tobacco use. Rooke C Sociol Health Illn; 2013 Mar; 35(3):361-76. PubMed ID: 22670865 [TBL] [Abstract][Full Text] [Related]
2. Medicalisation, smoking and e-cigarettes: evidence and implications. Morphett K; Carter A; Hall W; Gartner C Tob Control; 2017 Dec; 26(e2):e134-e139. PubMed ID: 27903957 [TBL] [Abstract][Full Text] [Related]
3. Making smokers different with nicotine: NRT and quitting. Keane H Int J Drug Policy; 2013 May; 24(3):189-95. PubMed ID: 23465645 [TBL] [Abstract][Full Text] [Related]
4. Tobacco harm reduction: conceptual structure and nomenclature for analysis and research. Shiffman S; Gitchell JG; Warner KE; Slade J; Henningfield JE; Pinney JM Nicotine Tob Res; 2002; 4 Suppl 2():S113-29. PubMed ID: 12573173 [TBL] [Abstract][Full Text] [Related]
5. Smokeless tobacco as a nicotine delivery device: harm or harm reduction? Benowitz NL Clin Pharmacol Ther; 2011 Oct; 90(4):491-3. PubMed ID: 21934719 [TBL] [Abstract][Full Text] [Related]
6. [Smoking reduction and temporary abstinence: new approaches for smoking cessation]. Le Houezec J; Säwe U J Mal Vasc; 2003 Dec; 28(5):293-300. PubMed ID: 14978435 [TBL] [Abstract][Full Text] [Related]
7. Does dual use jeopardize the potential role of smokeless tobacco in harm reduction? Frost-Pineda K; Appleton S; Fisher M; Fox K; Gaworski CL Nicotine Tob Res; 2010 Nov; 12(11):1055-67. PubMed ID: 20847148 [TBL] [Abstract][Full Text] [Related]
8. [Extreme solutions for those who do not succeed to quit smoking. About smokeless tobacco and harm reduction]. Trofor A; Eşanu V; Frăsilă EI Pneumologia; 2008; 57(2):105-8. PubMed ID: 18822878 [TBL] [Abstract][Full Text] [Related]
9. Harm reduction in U.S. tobacco control: Constructions in textual news media. Eversman MH Int J Drug Policy; 2015 Jun; 26(6):575-82. PubMed ID: 25727451 [TBL] [Abstract][Full Text] [Related]
10. Harm reduction policies for tobacco users. Gartner C; Hall W Int J Drug Policy; 2010 Mar; 21(2):129-30. PubMed ID: 19944582 [TBL] [Abstract][Full Text] [Related]
11. Tobacco, nicotine and harm reduction. Le Houezec J; McNeill A; Britton J Drug Alcohol Rev; 2011 Mar; 30(2):119-23. PubMed ID: 21375611 [TBL] [Abstract][Full Text] [Related]
12. [Extreme solutions for those who do not succeed to quit smoking. About smokeless tobacco and harm reduction (part II)]. Trofor A; Eşanu V; Frasilă EL Pneumologia; 2008; 57(3):178-81. PubMed ID: 18998333 [TBL] [Abstract][Full Text] [Related]
13. Tobacco harm reduction: the need for new products that can compete with cigarettes. Fagerström KO; Bridgman K Addict Behav; 2014 Mar; 39(3):507-11. PubMed ID: 24290207 [TBL] [Abstract][Full Text] [Related]
14. Patients' views on smoking cessation and tobacco harm reduction during drug treatment. Richter KP; McCool RM; Okuyemi KS; Mayo MS; Ahluwalia JS Nicotine Tob Res; 2002; 4 Suppl 2():S175-82. PubMed ID: 12573178 [TBL] [Abstract][Full Text] [Related]
16. Views and Preferences for Nicotine Products as an Alternative to Smoking: A Focus Group Study of People Living with Mental Disorders. Meurk C; Ford P; Sharma R; Fitzgerald L; Gartner C Int J Environ Res Public Health; 2016 Nov; 13(11):. PubMed ID: 27886046 [No Abstract] [Full Text] [Related]
17. Tobacco harm reduction: a call to address the ethical dilemmas. Fox BJ; Cohen JE Nicotine Tob Res; 2002; 4 Suppl 2():S81-7. PubMed ID: 12573170 [TBL] [Abstract][Full Text] [Related]
18. Crossing the line: adolescents' experiences of controlling their tobacco use. Johnson JL; Kalaw C; Lovato CY; Baillie L; Chambers NA Qual Health Res; 2004 Nov; 14(9):1276-91. PubMed ID: 15448300 [TBL] [Abstract][Full Text] [Related]
19. Tobacco harm reduction in people with serious mental illnesses. Gartner C; Hall W Lancet Psychiatry; 2015 Jun; 2(6):485-7. PubMed ID: 26360430 [No Abstract] [Full Text] [Related]
20. Tobacco harm reduction: how rational public policy could transform a pandemic. Sweanor D; Alcabes P; Drucker E Int J Drug Policy; 2007 Mar; 18(2):70-4. PubMed ID: 17689347 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]